Admera AtheroGxOne NGS-Based Panel
Mar 17, 2016
Admera Health has launched its AtheroGxOne. It is a comprehensive NGS-based 84-gene panel aimed at identifying patients with a genetic signature for inherited premature coronary or atherosclerotic disease, such as Familial Hypercholesterolemia or Mature Onset Diabetes of the Young. The panel completes the company's Cardiovascular Test Portfolio, which also includes CardioGxOne and PGxCardio.